TABLE 1.
Activities of antibacterial agents against 50 clinical isolates of M. pneumoniae and M. pneumoniae FH
| Antibacterial agent | MIC (μg/ml) for M. pneumoniaea
|
MIC (μg/ml) for M. pneumoniae FHb | ||
|---|---|---|---|---|
| Range | 50% | 90% | ||
| T-3811 | 0.0156–0.0625 | 0.0313 | 0.0313 | 0.0313 |
| Ciprofloxacin | 0.5–2 | 1 | 1 | 1 |
| Levofloxacin | 0.25–1 | 0.5 | 0.5 | 0.5 |
| Trovafloxacin | 0.0625–0.25 | 0.125 | 0.25 | 0.125 |
| Gatifloxacin | 0.0625–0.25 | 0.125 | 0.125 | 0.125 |
| Gemifloxacin | 0.0625–0.25 | 0.25 | 0.25 | 0.125 |
| Moxifloxacin | 0.0625–0.125 | 0.125 | 0.125 | 0.0625 |
| Clarithromycin | 0.002–0.0156 | 0.0078 | 0.0078 | 0.002 |
| Minocycline | 0.0625–1 | 0.5 | 1 | 0.0625 |
a
50%, MIC50; 90%, MIC90.
b
The strain used for experimental pneumonia.